- OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
- OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
- OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
- OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
- OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
- OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
- OptimizeRx to Participate in Upcoming Investor Conferences
- OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
- OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
- OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
More ▼
Key statistics
On Thursday, OPTIMIZERx Corp (OPRX:NAQ) closed at 9.35, 35.12% above the 52 week low of 6.92 set on Oct 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.61 |
---|---|
High | 9.92 |
Low | 9.33 |
Bid | 8.98 |
Offer | 9.43 |
Previous close | 9.53 |
Average volume | 108.71k |
---|---|
Shares outstanding | 18.15m |
Free float | 16.00m |
P/E (TTM) | -- |
Market cap | 172.99m USD |
EPS (TTM) | -1.02 USD |
Data delayed at least 15 minutes, as of Apr 18 2024 21:00 BST.
More ▼